Literature DB >> 22127108

Field cancerization in Barrett's esophagus.

Sebastian S Zeki1, Stuart A McDonald, Trevor A Graham.   

Abstract

Barrett's esophagus is a columnar metaplasia conferring an increased risk of adenocarcinoma development. Evidence suggests that this increased risk is due to field cancerization - the formation of histologically undistinguishable field of clonally derived, mutant cells within the Barrett's segment. Field cancerization can occur prior to both dysplasia and invasive neoplasia and potentially provides a mechanism for the development of multifocal and metachronous tumors. In the gastrointestinal tract, mutant clones spread predominately by crypt fission; the same is likely to be true in Barrett's lesions. Epithelial interactions in the form of cooperation or competition between epithelial clones, as well as with stromal cells, may further drive clone growth. Field cancerization is a clinically relevant phenomenon, knowledge of which could influence the size of resection margins to enhance prognosis after curative surgery, as well as provide a rationale for the development of effective biomarkers for neoplasia risk in Barrett's esophagus. This may provide a foundation for streamlined surveillance programs to prevent the development of invasive tumors.

Entities:  

Mesh:

Year:  2011        PMID: 22127108

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  5 in total

Review 1.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

Review 2.  Barrett oesophagus: lessons on its origins from the lesion itself.

Authors:  Stuart A C McDonald; Danielle Lavery; Nicholas A Wright; Marnix Jansen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-04       Impact factor: 46.802

3.  Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases.

Authors:  Berbel L M Ykema; Sanne J M Hoefnagel; Lisanne S Rigter; Liudmila L Kodach; Gerrit A Meijer; Flora E van Leeuwen; Hina N Khan; Petur Snaebjornsson; Berthe M P Aleman; Annegien Broeks; Sybren L Meijer; Kenneth K Wang; Beatriz Carvalho; Kausilia K Krishnadath; Monique E van Leerdam
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

4.  Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity.

Authors:  A C Katz-Summercorn; S Jammula; A Frangou; I Peneva; M O'Donovan; M Tripathi; S Malhotra; M di Pietro; S Abbas; G Devonshire; W Januszewicz; A Blasko; K Nowicki-Osuch; S MacRae; A Northrop; A M Redmond; D C Wedge; R C Fitzgerald
Journal:  Nat Commun       Date:  2022-03-17       Impact factor: 17.694

Review 5.  miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.

Authors:  Giovanni Zarrilli; Francesca Galuppini; Valentina Angerilli; Giada Munari; Marianna Sabbadin; Vanni Lazzarin; Lorenzo Nicolè; Rachele Biancotti; Matteo Fassan
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.